H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 123 Citations 74,021 450 World Ranking 1359 National Ranking 822

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Stroke
  • Surgery

His primary areas of study are Stroke, Surgery, Internal medicine, Anesthesia and Cardiology. The various areas that he examines in his Stroke study include Atrial fibrillation, Warfarin, Randomized controlled trial, Magnetic resonance imaging and Aspirin. His research investigates the link between Randomized controlled trial and topics such as Clinical trial that cross with problems in Physical therapy.

His research in Surgery intersects with topics in Thrombolysis, Placebo, Modified Rankin Scale and Desmoteplase. His Anesthesia research incorporates themes from Intracerebral hemorrhage and Antagonist. His Cardiology research focuses on Severity of illness and how it connects with Odds ratio.

His most cited work include:

  • Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. (2810 citations)
  • Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials (2100 citations)
  • Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging (1611 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Stroke, Internal medicine, Cardiology, Surgery and Magnetic resonance imaging. His Stroke research includes themes of Anesthesia, Clinical trial, Radiology and Perfusion scanning. The Aspirin, Atrial fibrillation, Modified Rankin Scale and Brain ischemia research Gregory W. Albers does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.

As part of the same scientific family, Gregory W. Albers usually focuses on Cardiology, concentrating on Ischemic stroke and intersecting with Endovascular therapy. His Surgery study combines topics from a wide range of disciplines, such as Tissue plasminogen activator and Fibrinolytic agent. Gregory W. Albers combines subjects such as Lesion, Nuclear medicine and Infarction with his study of Magnetic resonance imaging.

He most often published in these fields:

  • Stroke (64.52%)
  • Internal medicine (41.75%)
  • Cardiology (33.83%)

What were the highlights of his more recent work (between 2018-2021)?

  • Stroke (64.52%)
  • Internal medicine (41.75%)
  • Cardiology (33.83%)

In recent papers he was focusing on the following fields of study:

Gregory W. Albers spends much of his time researching Stroke, Internal medicine, Cardiology, Perfusion scanning and Ischemic stroke. The concepts of his Stroke study are interwoven with issues in Randomized controlled trial, Magnetic resonance imaging, Radiology and Clinical trial. In the subject of general Internal medicine, his work in Modified Rankin Scale, Large vessel occlusion, Occlusion and Infarct volume is often linked to In patient, thereby combining diverse domains of study.

His Cardiology research integrates issues from Cerebral infarction, Acute ischemic stroke and Core. He has included themes like Randomization, Prospective cohort study and Nuclear medicine in his Perfusion scanning study. His Ischemic stroke research is multidisciplinary, incorporating elements of Infarct size, Endovascular therapy and Surgery.

Between 2018 and 2021, his most popular works were:

  • Collateral Effect of Covid-19 on Stroke Evaluation in the United States. (233 citations)
  • Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (100 citations)
  • Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study. (32 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Stroke
  • Surgery

Gregory W. Albers mainly focuses on Stroke, Internal medicine, Cardiology, Perfusion scanning and Magnetic resonance imaging. His studies in Stroke integrate themes in fields like Occlusion, Randomized controlled trial and Perfusion. His Internal medicine research focuses on Triage and how it relates to White matter.

His Cardiology study incorporates themes from Infarct volume, Clinical trial, Cerebral infarction and Acute ischemic stroke. His work deals with themes such as Endovascular therapy and Cerebral blood flow, which intersect with Magnetic resonance imaging. His Modified Rankin Scale research is multidisciplinary, incorporating perspectives in Odds ratio and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Jeffrey L. Saver;Mayank Goyal;Alain Bonafe;Hans Christoph Diener.
The New England Journal of Medicine (2015)

3901 Citations

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)

3445 Citations

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)

2278 Citations

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

Gregory W. Albers;Michael P. Marks;Stephanie Kemp;Soren Christensen.
The New England Journal of Medicine (2018)

2158 Citations

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)

1888 Citations

Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease

J. Donald Easton;Jeffrey L. Saver;Gregory W. Albers;Mark J. Alberts.
Stroke (2009)

1806 Citations

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Karen L. Furie;Scott E. Kasner;Robert J. Adams;Gregory W. Albers.
Stroke (2011)

1801 Citations

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study: A Randomized Controlled Trial

Wayne M. Clark;Stanley Wissman;Gregory W. Albers;Jack H. Jhamandas.
JAMA (1999)

1572 Citations

Transient Ischemic Attack — Proposal for a New Definition

Gregory W. Albers;Louis R. Caplan;J. Donald Easton;Pierre B. Fayad.
The New England Journal of Medicine (2002)

1443 Citations

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial

J. L. Blackshear;V. S. Baker;F. Rubino;R. Safford.
The Lancet (1996)

1438 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gregory W. Albers

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 284

David S. Liebeskind

David S. Liebeskind

University of California, Los Angeles

Publications: 280

Jeffrey L Saver

Jeffrey L Saver

University of California, Los Angeles

Publications: 236

Michael D. Hill

Michael D. Hill

University of Calgary

Publications: 229

Andrew M. Demchuk

Andrew M. Demchuk

University of Calgary

Publications: 203

Mayank Goyal

Mayank Goyal

University of Calgary

Publications: 193

Stephen M. Davis

Stephen M. Davis

Royal Melbourne Hospital

Publications: 190

Mark W. Parsons

Mark W. Parsons

UNSW Sydney

Publications: 189

Geoffrey A. Donnan

Geoffrey A. Donnan

Royal Melbourne Hospital

Publications: 175

Lee H. Schwamm

Lee H. Schwamm

Harvard University

Publications: 173

Max Wintermark

Max Wintermark

Stanford University

Publications: 154

Hans-Christoph Diener

Hans-Christoph Diener

University of Duisburg-Essen

Publications: 147

Christopher R. Levi

Christopher R. Levi

John Hunter Hospital

Publications: 145

Werner Hacke

Werner Hacke

Heidelberg University

Publications: 144

Diederik W.J. Dippel

Diederik W.J. Dippel

Erasmus University Rotterdam

Publications: 131

Ralph L. Sacco

Ralph L. Sacco

University of Miami

Publications: 131

Something went wrong. Please try again later.